Genome-wide association studies have identified a protective mutation in the phospholipase C gamma 2 (PLCG2) gene which confers protection against Alzheimer’s disease (AD)-associated cognitive decline. This evidence concerns the gene PLCG2 and early-onset autosomal dominant Alzheimer disease.